Cargando…

Knowledge on malignant hyperthermia: as rare as the disease? A nation wide survey

Detalles Bibliográficos
Autores principales:	Wolvetang, Timothy, Hofland, Jan, Takkenberg, Hanneke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139669/ http://dx.doi.org/10.1186/1471-2253-14-S1-A18

Ejemplares similares

Malignant hyperthermia as a rare cause of SIRS after cardiac surgery
por: Theuerkauf, Nils, et al.
Publicado: (2014)

French guidelines for the management of malignant hyperthermia
por: Krivosic-Horber, René
Publicado: (2014)

Analysis of malignant hyperthermia results in Padua and Siena
por: Tegazzin, Vincenzo, et al.
Publicado: (2014)

Malignant hyperthermia on ICU – sudden attack of the “snake”
por: Johannsen, Stephan, et al.
Publicado: (2014)

Accuracy of the diagnosis of malignant hyperthermia in hospital discharge records
por: Pinyavat, Teeda, et al.
Publicado: (2014)

Malignant hyperthermia testing in probands with NO adverse anesthetic reaction
por: Sterling, Carly, et al.
Publicado: (2014)

Carnitine palmitoyltransferase 2 deficiency, malignant hyperthermia and anesthesia
por: Glauber, Violeta, et al.
Publicado: (2014)

Development and evolution of the MHAUS cognitive aid for malignant hyperthermia
por: Pinyavat, Teeda, et al.
Publicado: (2014)

Dantrolene in the treatment of malignant hyperthermia: a case report
por: Islander, Gunilla
Publicado: (2014)

Gene expression in the context of malignant hyperthermia status and ageing
por: Baines, Kathie Nicoll, et al.
Publicado: (2014)

Malignant hyperthermia mutations and correlation with the severity of the anesthetic complication and the level of the in vitro contracture tests
por: Krivosic-Horber, René, et al.
Publicado: (2014)

Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
por: Fiszer, Dorota, et al.
Publicado: (2014)

Preferential allele amplification leading to RyR1 misgenotyping in a malignant hyperthermia susceptible individual
por: Gonzalez, Asensio, et al.
Publicado: (2014)

Update of the quality assurance (QA) results of halothane and caffeine analysis of all current participating malignant hyperthermia units
por: Fisher, Nickla, et al.
Publicado: (2014)

Recommendations for the development of national plans for rare diseases
por: Van der Zeijden, Albert, et al.
Publicado: (2010)

National Rare Disease Registries: overview from Spain
por: de la Paz, M Posada, et al.
Publicado: (2014)

The French national registry for rare diseases: an integrated model from care to epidemiology and research
por: Choquet, Rémy, et al.
Publicado: (2014)

Saudi national science, technology and innovation plan towards knowledge based economy
por: Al-Swailem, Abdulaziz M
Publicado: (2014)

Intraoperative tachycardia, hypercapnia, hyperthermia and muscle stiffness in a dantrolene unavailability case. Can calcium channel blockers be valuable?
por: Marques, Acílio, et al.
Publicado: (2014)

Development of a malignant hyperthermia protocol
por: Yeung, EYH, et al.
Publicado: (2015)

Implementation of sonication and feedback control strategies for targeted hyperthermia in prostate with a commercial MR-guided endorectal ultrasound ablation array
por: Salgaonkar, Vasant, et al.
Publicado: (2015)

The Swedish rare disease information database and the Swedish information centre for rare diseases
por: Greek-Winald, Christina, et al.
Publicado: (2010)

100 telephone conversations about malignant hyperthermia
por: Petersen, Bodil, et al.
Publicado: (2014)

Determinants for research on rare diseases
por: Palau, Francesc
Publicado: (2010)

Ageing in rare, chronic diseases
por: Smit, Cees
Publicado: (2010)

O035: Third federal state wide survey on MRSA management in North Rhine-Westphalian hospitals
por: Jurke, A, et al.
Publicado: (2013)

O051: European medical students and antibiotic stewardship: a multicentre survey of knowledge, attitudes and beliefs
por: Dyar, OJ, et al.
Publicado: (2013)

RARE-Bestpractices: a platform for sharing best practices for the management of rare diseases
por: Taruscio, D, et al.
Publicado: (2014)

Roe deer used as indicator species for a country wide survey for the occurrence of Tick Borne Encephalitis in Austria
por: Duscher, GG, et al.
Publicado: (2014)

French experience with rare diseases plans
por: Le Henanff, Guillaume, et al.
Publicado: (2010)

Which support from the French Foundation of rare disease towards clinical trial set up in rare diseases?
por: Ravagnan, Luigi
Publicado: (2015)

Sonographic assessment of extent and aggressiveness of malignant breast disease
por: Stavros, T
Publicado: (2004)

The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development
por: Tambuyzer, Erik T, et al.
Publicado: (2014)

How to code rare diseases with international terminologies?
por: Rath, Ana, et al.
Publicado: (2014)

Malignant hyperthermia and beyond - a virtual BioBank
por: Underwood, Rosie, et al.
Publicado: (2014)

Current provision for MRI scanning of patients with cardiac implantable electronic devices - a national survey of hospitals in England
por: Oldman, James L, et al.
Publicado: (2016)

Structures and activities of Drug and Therapeutic Committees in formulary management: findings from a national survey and key informant interviews
por: Ramli, Azuana, et al.
Publicado: (2014)

A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
por: Broen, Jasper CA, et al.
Publicado: (2011)

Patient innovation under rare diseases and chronic needs
por: Oliveira, Pedro, et al.
Publicado: (2014)

Towards a European platform for Rare Diseases Registries
por: Nicholl, Ciarán
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9mhagd40lg6cvbjbh2r5busc7c